The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MET amplification occurrence and prediction of unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy.
Yu-hong Li
No relevant relationships to disclose
Xin An
No relevant relationships to disclose
Fang Wang
No relevant relationships to disclose
Qiong Shao
No relevant relationships to disclose
Feng-Hua Wang
No relevant relationships to disclose
Zhiqiang Wang
No relevant relationships to disclose
Cui Chen
No relevant relationships to disclose
Cong Li
No relevant relationships to disclose
Huiyan Luo
No relevant relationships to disclose
Sheng Dong Zhang
No relevant relationships to disclose
Rui-hua Xu
No relevant relationships to disclose